Background: Limitations of the clinical efficacy of dendritic cell (DC)-based immunotherapy, as well as difficulties in their industrial production, are largely related to the limited number of autologous DCs from each patient. We here established a possible breakthrough, a simple and cytokine-based culture method to realize a log-scale order of functional murine DCs (>1,000-fold), which cells were used as a model before moving to human studies. Methodology/Principal Findings: Floating cultivation of lineage-negative hematopoietic progenitors from bone marrow in an optimized cytokine cocktail (FLT3-L, IL-3, IL-6, and SCF) led to a stable log-scale proliferation of these cells, and a subsequent differentiation study using IL-4/GM-CSF revealed that 3-weeks of expansion was optimal to produce CD11b+/CD11c+ DC-like cells. The expanded DCs had typical features of conventional myeloid DCs in vitro and in vivo, including identical efficacy as tumor vaccines. Conclusions/Significance: The concept of DC expansion should make a significant contribution to the progress of DC-based immunotherapy. © 2009 Harada et al.
CITATION STYLE
Harada, Y., Ueda, Y., Kinoh, H., Komaru, A., Fuji-Ogawa, T., Furuya, A., … Yonemitsu, Y. (2009). Cytokine-based log-scale expansion of functional murine dendritic cells. PLoS ONE, 4(8). https://doi.org/10.1371/journal.pone.0006674
Mendeley helps you to discover research relevant for your work.